Literature DB >> 23715168

A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins.

Elisha M Singer, Karolyn A Wanat, Misha A Rosenbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23715168     DOI： 10.1001/jamadermatol.2013.1949

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.

Authors:  Muhammad Riaz; Bruce D Ragsdale; Zia Ur Rahman; Gaurav Nigam
Journal:  BMJ Case Rep       Date:  2017-08-22

Review 2.  Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and Management.

Authors:  S Shahzad Mustafa; David Ostrov; Daniel Yerly
Journal:  Curr Allergy Asthma Rep       Date:  2018-03-24       Impact factor: 4.806

3.  Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.

Authors:  Natsumi Hama; Riichiro Abe; Andrew Gibson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-15

4.  Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS.

Authors:  Mingqun Deng; Han Wu; Miao Yu; Yi Tian; Yuxiu Li; Xinhua Xiao
Journal:  Int J Endocrinol       Date:  2019-10-03       Impact factor: 3.257

5.  Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report.

Authors:  Elise Hyser
Journal:  J Med Case Rep       Date:  2022-09-05

Review 6.  Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome.

Authors:  Chiyo Morita; Tetsuji Yanase; Tetsuo Shiohara; Yumi Aoyama
Journal:  BMJ Case Rep       Date:  2018-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.